I-MAB Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell

19

IMAB
I-MAB

Last Price:

1.11

Seasonality Move:

6.08%

Sell

18

NBY
NovaBay Pharmaceuticals

Last Price:

0.55

Seasonality Move:

-6.61%

Sell

19

I-MAB (IMAB) is a Sell

Is I-MAB a Buy, Sell or Hold?

The current I-MAB [IMAB] share price is $1.02. The Score for IMAB is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
IMAB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

18

NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

The current NovaBay Pharmaceuticals [NBY] share price is $0.57. The Score for NBY is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

IMAB Stock Price Chart

What is I-MAB's stock price today?

The I-MAB share price today is $1.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMAB is experiencing slight buying pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

The NovaBay Pharmaceuticals share price today is $0.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

IMAB Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.06	Sell
Relative Strength Index (14 RSI):	46.54	Sell
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.96 - 1.1)	Sell
Bollinger Bands (100):	(1.02 - 1.36)	Sell

NBY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.02	Sell
Relative Strength Index (14 RSI):	35.79	Sell
Chaikin Money Flow:	-12542	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.63 - 0.75)	Sell
Bollinger Bands (100):	(0.29 - 1.21)	Sell

IMAB Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.96	Buy
20-day SMA:	1.01	Buy
50-day SMA:	1.16	Sell
200-day SMA:	1.48	Sell
8-day EMA:	0.98	Buy
20-day EMA:	1.02	Buy
50-day EMA:	1.11	Sell
200-day EMA:	1.5	Sell

NBY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.63	Sell
20-day SMA:	0.68	Sell
50-day SMA:	0.67	Sell
200-day SMA:	2.19	Sell
8-day EMA:	0.62	Sell
20-day EMA:	0.65	Sell
50-day EMA:	0.7	Sell
200-day EMA:	5.28	Sell

I-MAB Earnings Growth & IMAB Earnings Dates

Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.72 per share, and a decrease next year of $0.53 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

I-MAB Technical Analysis

	Nov 19	Nov 20	Nov 21	Nov 22	Nov 25	Nov 26	Nov 27	Nov 29	Dec 2	Dec 3
	Nov									Dec
	19	20	21	22	25	26	27	29	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

	Nov 19	Nov 20	Nov 21	Nov 22	Nov 25	Nov 26	Nov 27	Nov 29	Dec 2	Dec 3
	Nov									Dec
	19	20	21	22	25	26	27	29	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):